Samtica (Abiraterone) 250 mg

Indicated for metastatic prostate cancer (mCRPC and mHSPC):

• 🎗️ Castration-Resistant Prostate Cancer: When the disease progresses despite standard androgen deprivation therapy (ADT).
• 🎗️ High-Risk Castration-Sensitive Prostate Cancer: Used in newly diagnosed metastatic cases for better control.

Packaging: Bottle of 120 Tablets (250 mg each). Supply for 1 month.

⚠️ ADMINISTRATION PROTOCOL:

• 💊 Standard Dose: 1,000 mg (4 tablets) taken once daily.
• 🍽️ EMPTY STOMACH ONLY! No food should be consumed for at least 2 hours before and 1 hour after taking the tablets. Taking it with food can lead to dangerous overdose levels.
• 💊 Combination Therapy: Must be taken with low-dose Prednisone/Prednisolone to prevent hypertension and fluid retention.

• Severe hepatic (liver) impairment.
• Women who are or may become pregnant should not handle the tablets without protection.
• Hypersensitivity to the active substance.

Common side effects to monitor:

• 🦵 Fluid Retention: Swelling in legs or feet (Peripheral edema).
• ❤️ Hypertension & Hypokalemia: High blood pressure and low potassium levels (managed by taking Prednisone).
• Elevated liver enzymes (ALT/AST). Regular blood tests are required.